TECX — Tectonic Therapeutic Cashflow Statement
0.000.00%
Last trade - 00:00- $573.06m
- $319.65m
Annual cashflow statement for Tectonic Therapeutic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.93 | -32.2 | -42.8 | -58 | -74.2 |
| Depreciation | |||||
| Non-Cash Items | -5.81 | 1.7 | 1.25 | 7.54 | 12.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.92 | 1.84 | -0.584 | -10.3 | -0.07 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.5 | -27.6 | -40.7 | -59.1 | -60.1 |
| Capital Expenditures | -2.12 | -2.09 | -0.279 | -0.156 | -0.208 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.07 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -2.12 | -2.09 | -0.279 | -0.156 | -0.138 |
| Financing Cash Flow Items | — | 0 | 34.1 | 76 | -0.485 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 41.4 | 37.6 | 33.7 | 172 | 173 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26.8 | 7.9 | -7.2 | 112 | 113 |